Physician profile
Minerva Pineiro
NPI 1255382669
$1,265.37
in general payments reported to CMS, 2019-2025
19 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $271 · 2021: $292 · 2022: $74.76 · 2023: $115 · 2024: $117 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $471.51 | 2019-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $134.96 | 2025 | |
| Abbvie INC. | $81.94 | 2021-2025 | |
| Amgen INC. | $76.35 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $67.11 | 2019-2022 | |
| Corcept Therapeutics | $63.88 | 2024-2025 | Korlym |
| Astrazeneca Pharmaceuticals Lp | $56.18 | 2019-2024 | Airsupra |
| Pfizer INC. | $50.55 | 2020-2021 | |
| Lilly USA, LLC | $43.90 | 2020-2021 | |
| Eisai INC. | $40.75 | 2020 | |
| Genentech USA, INC. | $39.26 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.79 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.16 | 2019 | |
| Merck Sharp & Dohme LLC | $17.85 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.03 | 2023 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.84 | 2019 | |
| Adlon Therapeutics L.P. | $12.45 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minerva Pineiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.